NCT03997890

Brief Summary

In With increased patients' demand for a spectacle-free lifestyle and technological advancements, cataract surgery with multifocal intraocular lens (IOL) implantation has become an effective solution for correcting presbyopia in patients who want to maintain their full range of vision. Conventional bifocal IOLs used either refractive or diffractive optics to split the light and create 2 principal focal points, thus providing functional vision at distance and near. This simultaneous imaging principle produces a sharp image that is overlaid by a secondary blurred out-of focus image, so these IOLs inherently produce a deterioration in contrast sensitivity and unwanted photic phenomena such as glare and halos. Additionally, studies reported insufficient intermediate vision with bifocal IOLs. There is an increasing desire for spectacle independence at intermediate distance, especially due to the increased use of computers and smartphones. Trifocal IOLs were introduced to the market in 2010 and participants provide an additional, third focal point to improve intermediate vision without compromising distance and near vision. However, participants are still vulnerable to decreased contrast sensitivity and photic phenomena due to the IOL's mechanism of splitting the light into discrete focal points. An extended depth of focus (EDOF) technology was recently introduced with the aim to improve intermediate vision while maintaining image contrast. The diffractive echelette design, embedded on its posterior optical surface, extends the range of vision and the achromatic technology reduces corneal chromatic aberrations to enhance retinal image quality and improve contrast sensitivity. The elongated focus allows imaging in a continuous range of vision without overlapping near and far images, and therefore theoretically would provide a more consistent distance and intermediate vision with less dysphotopsia. The aim of this study was to investigate the clinical outcome of patients bilaterally implanted with either Tecnis Symfony or Tecnis Symfony toric extended range of vision IOLs (Johnson \& Johnson Vision, Santa Ana, CA, USA) in terms of visual performance at different distances, spectacle independence, photic phenomena, and patient satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 13, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2018

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 18, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 25, 2019

Completed
Last Updated

June 27, 2019

Status Verified

June 1, 2019

Enrollment Period

1.5 years

First QC Date

June 18, 2019

Last Update Submit

June 24, 2019

Conditions

Keywords

Extended depth of focusMultifocal intraocular lensPresbyopiaCataract surgery

Outcome Measures

Primary Outcomes (8)

  • Visual outcome

    1\. Uncorrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

    preoperative 4-6 weeks

  • Visual outcome

    2\. Corrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

    preoperative 4-6 weeks

  • Visual outcome

    3\. Uncorrected Intermediate Visual Acuity (70 cm) in logMAR scale at each time point.

    preoperative 4-6 weeks

  • Visual outcome

    4\. Uncorrected Near Visual Acuity (40 cm) in logMAR scale at each time point.

    preoperative 4-6 weeks

  • Visual outcome

    1\. Uncorrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

    preoperative 4-6 months

  • Visual outcome

    2\. Corrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

    preoperative 4-6 months

  • Visual outcome

    3\. Uncorrected Intermediate Visual Acuity (70 cm) in logMAR scale at each time point.

    preoperative 4-6 months

  • Visual outcome

    4\. Uncorrected Near Visual Acuity (40 cm) in logMAR scale at each time point.

    preoperative 4-6 months

Secondary Outcomes (6)

  • Spectacle use

    Postoperative 4-6 weeks

  • Spectacle use

    Postoperative 4-6 months

  • Photic phenomena

    Postoperative 4-6 weeks

  • Photic phenomena

    Postoperative 4-6 months

  • Patient Satisfaction

    Postoperative 4-6 weeks

  • +1 more secondary outcomes

Study Arms (1)

Symfony group

EXPERIMENTAL

The subjects who underwent cataract surgery with binocular implantation of either Symfony or Symfony toric IOLs

Procedure: Cataract surgery with binocular implantation of either Symfony (ZXR00) or Symfony toric (ZXT) IOLs

Interventions

After creating an initial side port incision with a 15-degree blade, 3-step clear corneal incisions were made using a 2.5 mm disposable metal blade. Sodium hyaluronate 1.0% (Healon; Abbott Medical Optics) was then injected into the anterior chamber. A continuous curvilinear capsulorrhexis, measuring 5.5 mm in diameter, was generated using a 26 gauge bent needle. After hydrodissection, phacoemulsification was done to remove nuclear fragments and aspiration of residual cortex. In all eyes, a Symfony or Symfony toric IOL was implanted in the capsular bag using a disposable implantation system. Irrigation and aspiration were performed to minimize ophthalmic viscoelastic surgical device retention at the end of surgery. The main incision and side port were sealed with stromal hydration using a balanced salt solution.

Symfony group

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Age of 20 years or older
  • \. Cataract

You may not qualify if:

  • \. Amblyopia
  • \. Keratoconus
  • \. Previous corneal or refractive surgery
  • \. Chronic or recurrent uveitis
  • \. Acute ocular disease
  • \. Previous ocular surgeries
  • \. Glaucoma
  • \. Any ocular disease which could possible affect the postoperative visual acuity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology, Yonsei Univeristy College of Medicine

Seoul, 03722, South Korea

Location

MeSH Terms

Conditions

CataractPresbyopia

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesRefractive Errors

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2019

First Posted

June 25, 2019

Study Start

July 13, 2016

Primary Completion

January 18, 2018

Study Completion

January 18, 2018

Last Updated

June 27, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations